Related references
Note: Only part of the references are listed.Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis
Jeongeun Hyun et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver
Vanessa Dubois et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury
Lara Planas-Paz et al.
CELL STEM CELL (2019)
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Josepmaria Argemie et al.
NATURE COMMUNICATIONS (2019)
Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles
Stefaan Verhulst et al.
CELLS (2019)
Dysregulated activation of fetal liver programme in acute liver failure
Jeongeun Hyun et al.
GUT (2019)
Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine
Ivan M. Moya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss
Christoph Tschuor et al.
FASEB BIOADVANCES (2019)
Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials
Alexandre Louvet et al.
GASTROENTEROLOGY (2018)
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Sachin H. Patel et al.
GASTROENTEROLOGY (2017)
A Single-Cell Transcriptomic Analysis Reveals Precise Pathways and Regulatory Mechanisms Underlying Hepatoblast Differentiation
Li Yang et al.
HEPATOLOGY (2017)
Alcoholic Hepatitis: Translational Approaches to Develop Targeted Therapies
Pranoti Mandrekar et al.
HEPATOLOGY (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis
Laurent Dubuquoy et al.
GUT (2015)
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
Dean Yimlamai et al.
JOURNAL OF HEPATOLOGY (2015)
Alcoholic liver disease: mechanisms of injury and targeted treatment
Alexandre Louvet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Julien Fitamant et al.
CELL REPORTS (2015)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis
Pau Sancho-Bru et al.
HEPATOLOGY (2012)
Cannabinoid CB2 Receptors Protect Against Alcoholic Liver Disease by Regulating Kupffer Cell Polarization in Mice
Alexandre Louvet et al.
HEPATOLOGY (2011)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice
Eyman Osman et al.
ATHEROSCLEROSIS (2009)
MEDICAL PROGRESS Alcoholic Hepatitis
Michael R. Lucey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The emerging role of the Hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
Qi Zeng et al.
CANCER CELL (2008)
The Lille model:: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids
Alexandre Louvet et al.
HEPATOLOGY (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Share Paper
